Roland Jimenez

1.6k total citations
45 papers, 1.1k citations indexed

About

Roland Jimenez is a scholar working on Psychiatry and Mental health, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Roland Jimenez has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 11 papers in Molecular Biology and 11 papers in Reproductive Medicine. Recurrent topics in Roland Jimenez's work include Endometriosis Research and Treatment (9 papers), Schizophrenia research and treatment (9 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Roland Jimenez is often cited by papers focused on Endometriosis Research and Treatment (9 papers), Schizophrenia research and treatment (9 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Roland Jimenez collaborates with scholars based in United States, France and Chile. Roland Jimenez's co-authors include Joshua Burke, Christopher O’Brien, Stewart A. Factor, Robert A. Hauser, Grace Liang, Ping Jiang, Kristof Chwalisż, Harry E. Gruber, W. Paul Dmowski and Bruce R. Carr and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Roland Jimenez

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Jimenez United States 15 369 293 245 232 207 45 1.1k
Matteo Cassina Italy 21 55 0.1× 133 0.5× 88 0.4× 146 0.6× 137 0.7× 60 1.4k
B. Velkeniers Belgium 16 101 0.3× 47 0.2× 30 0.1× 32 0.1× 67 0.3× 43 655
Madhu Chauhan United States 19 66 0.2× 252 0.9× 87 0.4× 10 0.0× 31 0.1× 44 777
H. Ben‐Hur Israel 13 109 0.3× 49 0.2× 44 0.2× 13 0.1× 49 0.2× 37 798
Naci Çine Türkiye 18 50 0.1× 23 0.1× 68 0.3× 20 0.1× 65 0.3× 61 687
Мilan Petakov Serbia 21 233 0.6× 30 0.1× 20 0.1× 50 0.2× 36 0.2× 88 1.3k
Antonio Masala Italy 16 131 0.4× 18 0.1× 49 0.2× 23 0.1× 50 0.2× 69 902
Michael Silver United States 15 49 0.1× 29 0.1× 29 0.1× 69 0.3× 67 0.3× 22 598
Lars Schlotawa Germany 13 78 0.2× 20 0.1× 43 0.2× 45 0.2× 110 0.5× 29 621
Doris Pfeiffer Germany 16 111 0.3× 48 0.2× 11 0.0× 17 0.1× 94 0.5× 41 763

Countries citing papers authored by Roland Jimenez

Since Specialization
Citations

This map shows the geographic impact of Roland Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Jimenez more than expected).

Fields of papers citing papers by Roland Jimenez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Jimenez. The network helps show where Roland Jimenez may publish in the future.

Co-authorship network of co-authors of Roland Jimenez

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Jimenez. A scholar is included among the top collaborators of Roland Jimenez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Jimenez. Roland Jimenez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jimenez, Roland, Edith Álvarez-León, Wylly Ramsés García‐Niño, et al.. (2024). Quercetin preserves mitochondria-endoplasmic reticulum contact sites improving mitochondrial dynamics in aged myocardial cells. Biogerontology. 26(1). 29–29. 6 indexed citations
3.
Jimenez, Roland, et al.. (2021). Colchicine in patients with acute myocardial infarction: an updated meta-analysis of randomized controlled trials. European Heart Journal. 42(Supplement_1). 2 indexed citations
4.
Smith, Evan, et al.. (2020). Effect of Paroxetine on the Pharmacokinetics of Valbenazine and its Active Metabolite (9). Neurology. 94(15_supplement). 1 indexed citations
5.
Loewen, Gordon, Peter A. LeWitt, Karl Kieburtz, et al.. (2019). Pharmacokinetics of Opicapone and Effect on Comt and Levodopa Pharmacokinetics in Patients with Parkinson's Disease. 34. 2 indexed citations
6.
Factor, Stewart A., John M. Kane, Stephen R. Marder, et al.. (2018). Effects of Long-Term Valbenazine on Tardive Dyskinesia and Patient-Reported Outcomes: Results from the KINECT 4 Study (P4.078). Neurology. 90(15_supplement). 1 indexed citations
7.
Jimenez, Roland, et al.. (2018). Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group. American Journal of Geriatric Psychiatry. 26(3). S159–S159. 1 indexed citations
8.
O’Brien, Christopher, et al.. (2017). Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials. Drug Safety. 41(4). 429–440. 12 indexed citations
9.
Factor, Stewart A., Gary Remington, Cynthia Comella, et al.. (2017). The Effects of Valbenazine in Participants with Tardive Dyskinesia. The Journal of Clinical Psychiatry. 78(9). 1344–1350. 65 indexed citations
10.
Bari, Mohammed Abdul, et al.. (2016). Open-Label Extension of KINECT: A Phase 2 Study of Valbenazine (NBI-98854) for Tardive Dyskinesia (S27.001). Neurology. 86(16_supplement). 5 indexed citations
11.
O’Brien, Christopher, et al.. (2015). NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study. Movement Disorders. 30(12). 1681–1687. 100 indexed citations
12.
Gallacher, A, Roger A. Levy, Mathew Thomas, et al.. (2009). Late‐breaking abstracts: American College of Rheumatology 2009 Annual Scientific Meeting. Arthritis & Rheumatism. 60(12). 3859–3861. 4 indexed citations
13.
Imani, Reza, et al.. (2009). Petal study: safety, tolerability and effectiveness of elagolix, an oral GnRH antagonist for endometriosis. Fertility and Sterility. 92(3). S111–S112. 6 indexed citations
14.
Walter, Markus, et al.. (2009). No Effect of the Altered Peptide Ligand NBI-6024 on β-Cell Residual Function and Insulin Needs in New-Onset Type 1 Diabetes. Diabetes Care. 32(11). 2036–2040. 83 indexed citations
15.
Jimenez, Roland, et al.. (1995). ESQUIZOFRENIA EN EL MEDIO COMUNITARIO. SHILAP Revista de lepidopterología. 15(53). 199–216. 2 indexed citations
16.
Barankiewicz, Jerzy, et al.. (1995). Endogenous Adenosine Formation can Regulate Human Neutrophil Function. Advances in experimental medicine and biology. 370. 417–421. 4 indexed citations
17.
Firestein, Gary S., David A. Bullough, Mark D. Erion, et al.. (1995). Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins.. The Journal of Immunology. 154(1). 326–334. 87 indexed citations
18.
Barankiewicz, J., et al.. (1991). Regulation of Adenosine Concentrations by Acadesine (Aica-Riboside) in Human B-Lymphoblasts. Advances in experimental medicine and biology. 309A. 275–278. 2 indexed citations
19.
Gruber, Harry E., Roland Jimenez, & J. Barankiewicz. (1991). Z-Nucleotides Formation in Human and Rat Cells. Advances in experimental medicine and biology. 309B. 363–366. 2 indexed citations
20.
Barankiewicz, Jerzy, et al.. (1990). Alteration of purine metabolism by AICA-riboside in human B lymphoblasts. Archives of Biochemistry and Biophysics. 282(2). 377–385. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matteo Cassina Breakdown of academic impact, for papers by B. Velkeniers Breakdown of academic impact, for papers by Madhu Chauhan Breakdown of academic impact, for papers by H. Ben‐Hur Breakdown of academic impact, for papers by Naci Çine Breakdown of academic impact, for papers by Мilan Petakov Breakdown of academic impact, for papers by Antonio Masala Breakdown of academic impact, for papers by Michael Silver Breakdown of academic impact, for papers by Lars Schlotawa Breakdown of academic impact, for papers by Doris Pfeiffer
Rankless by CCL
2026